Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A
humanized monoclonal antibody .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word elotuzumab.
Examples
-
The company is looking to move elotuzumab, which is being developed with
-
The company's current clinical-stage programs consist of daclizumab for the treatment of multiple sclerosis, currently in a second phase 2 trial; volociximab, currently in phase 1 / 2 studies in ovarian and non-small cell lung cancer; elotuzumab, which is in three phase 1 studies in patients with multiple myeloma; and PDL192, which is in a phase 1 study in various solid tumors.
San Jose Business News - Local San Jose News | The Silicon Valley / San Jose Business Journal 2009
-
As for the rest of the pipeline, Facet is currently investigating volociximab in various open-label clinical trials in patients with advanced solid tumours, again with Biogen and is collaborating with Bristol-Myers Squibb on elotuzumab which is in Phase I studies for multiple myeloma.
-
As for the rest of the pipeline, Facet is currently investigating volociximab in various open-label clinical trials in patients with advanced solid tumours, again with Biogen and is collaborating with Bristol-Myers Squibb on elotuzumab which is in Phase I studies for multiple myeloma.
-
Among the other immunologic drugs, elotuzumab is probably the farthest along, with a final-stage study underway in patients with multiple myeloma, or bone marrow cancer.
-
Among the other immunologic drugs, elotuzumab is probably the farthest along, with a final-stage study underway in patients with multiple myeloma, or bone marrow cancer.
-
Among the other immunologic drugs, elotuzumab is probably the farthest along, with a final-stage study underway in patients with multiple myeloma, or bone marrow cancer.
-
Among the other immunologic drugs, elotuzumab is probably the farthest along, with a final-stage study underway in patients with multiple myeloma, or bone marrow cancer.
-
Among Facet's assets is the Phase I multiple myeloma drug elotuzumab.
San Francisco Business News - Local San Francisco News | The San Francisco Business Times 2009
-
Biogen Idec Inc., the former employer of Facet President and CEO Faheem Hasnain, while elotuzumab is in development with
San Francisco Business News - Local San Francisco News | The San Francisco Business Times 2009
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.